|
Apr 18
|
Company News for Apr 18, 2024
|
|
Apr 18
|
Eli Lilly's (LLY) Tirzepatide Meets Goals in Sleep Apnea Studies
|
|
Apr 18
|
14 Best Large Cap Dividend Growth Stocks To Buy Now
|
|
Apr 18
|
2 Growth Stocks That Turned $10,000 Into More Than $100,000 in Just 10 Years
|
|
Apr 18
|
The Zacks Analyst Blog Highlights Eli Lilly, Linde, Caterpillar, Salesforce, and Wells Fargo
|
|
Apr 18
|
Metsera, a well-funded obesity drug startup, sees chance to challenge Lilly, Novo
|
|
Apr 17
|
Why Eli Lilly Stock Beat the Market Today While ResMed and AdaptHealth Sank
|
|
Apr 17
|
Top Research Reports for Eli Lilly, Linde & Caterpillar
|
|
Apr 17
|
Stocks Fall After Fed Data; Nvidia Tests Key Level While Tesla's Musk Faces Shareholder Vote
|
|
Apr 17
|
Eli Lilly Pops After Weight-Loss Drug Succeeds In Highly Anticipated Sleep Apnea Test
|
|
Apr 17
|
Eli Lilly's weight loss drug could help sleep apnea patients
|
|
Apr 17
|
Eli Lilly's Famed Weight Loss Drug Zepbound Works As Sleep Apnea Treatment, Successful Late-Stage Studies Show
|
|
Apr 17
|
Eli Lilly’s Zepbound Weight Loss Drug Works on Sleep Apnea, Too
|
|
Apr 17
|
US STOCKS-Wall St gains from megacaps thrust; earnings, Fed comments on tap
|
|
Apr 17
|
Eli Lilly Stock Gains After Study Shows Weight-Loss Drug Combats Sleep Apnea
|
|
Apr 15
|
Jim Cramer is Recommending These 10 Stocks in April
|
|
Apr 15
|
More than 250 websites selling fake weight-loss drugs reported by anti-counterfeit firm
|
|
Apr 13
|
Jim Cramer’s 10 Favorite Healthcare Stock Picks in 2024
|
|
Apr 13
|
3 Magnificent Stocks That Could Double or More by 2030
|
|
Apr 12
|
Eli Lilly, Novo Euphoria Risks Disappointing Investors, Goldman Says
|